... telaprevir. The drug works by blocking an enzyme that the hepatitis C virus needs in order to replicate ... adding telaprevir make standard hepatitis C treatment more effective, but it makes it work much ...
... The new marker is a single letter change – a C instead of a T – in a tiny segment of DNA near ... biological marker related to response to hepatitis C treatments, but at the same time, the findings tell ...
A statin drug used to lower cholesterol has been found to stop hepatitis C, especially in patients resistant to standard treatment. The drug, Fluvastatin, has been approved since 1993 by the U.S. Food ...
... NASH), which can lead to liver cancer. Chronic hepatitis C also increases the risk of liver cancer ... along with fibrosis assessment and details of hepatitis C treatment.
Eighty-five of the 541 patients ...
... that treatment is cost-saving and should not be withheld in U.S. prisoners with hepatitis C."
Since the efficacy of treatment would be diminished by relapse to injection drug use and re-infection, ...
Treating all US prisoners who have hepatitis C with the standard therapy of pegylated-interferon and ribavirin would be cost-effective, says a new study.
... of newly-identified proteins may be able to predict who will most likely respond to standard therapy for hepatitis C infection, say researchers in the Duke Clinical Research Institute (DCRI). It is a ...
... M.D., project scientist for HALT-C in the Division of Digestive Diseases and Nutrition, National ... 050 patients with chronic hepatitis C who had failed prior treatment to eradicate the infection, tested ...
Treating patients who have chronic hepatitis C and advanced liver disease with long-term pegylated interferon significantly decreased their liver enzymes, viral levels and ...
The most effective treatment for hepatitis C fails in two-thirds of Hispanic patients but works for half of white patients, researchers reported Wednesday in a ...
... -viral drug telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and increase ... common type of hepatitis C is 48 weeks of a combination of two drugs, peginterferon alfa ...
DURHAM, N.C., May 4 (UPI) -- U.S. medical researchers say they've found the addition of the anti-viral drug telaprevir significantly benefits the standard treatment for hepatitis C.
For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances ...
... t seem to make any difference which treatment a physician gives a patient," said Dr. William ... treat form of hepatitis C virus infection. Participants, who had not received prior treatment, were assigned ...
... Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (VIRAHEP-C), 260 men treated ... ribavirin. In fact, most review articles on hepatitis C treatment, summary publications on the side effects ...
